company background image
EDAP

EDAP TMS NasdaqGM:EDAP Stock Report

Last Price

US$8.12

Market Cap

US$271.6m

7D

-8.5%

1Y

25.8%

Updated

28 Sep, 2022

Data

Company Financials +
EDAP fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance5/6
Financial Health4/6
Dividends0/6

EDAP Stock Overview

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally.

EDAP TMS Competitors

Price History & Performance

Summary of all time highs, changes and price drops for EDAP TMS
Historical stock prices
Current Share PriceUS$8.12
52 Week HighUS$8.99
52 Week LowUS$5.00
Beta1.25
1 Month Change-5.53%
3 Month Change19.34%
1 Year Change25.81%
3 Year Change85.70%
5 Year Change166.07%
Change since IPO-4.53%

Recent News & Updates

Sep 22

EDAP TMS stock falls 7% aftermarket on proposed ADS offering

EDAP TMS (NASDAQ:EDAP) stock fell ~7% postmarket after the company said it commenced a public offering of its American depositary shares, each representing one ordinary share. There can be no assurance as to whether or when the proposed offering may be completed or the actual size or terms.

Shareholder Returns

EDAPUS Medical EquipmentUS Market
7D-8.5%-2.2%-2.0%
1Y25.8%-30.1%-20.3%

Return vs Industry: EDAP exceeded the US Medical Equipment industry which returned -31.4% over the past year.

Return vs Market: EDAP exceeded the US Market which returned -22.1% over the past year.

Price Volatility

Is EDAP's price volatile compared to industry and market?
EDAP volatility
EDAP Average Weekly Movement8.3%
Medical Equipment Industry Average Movement8.6%
Market Average Movement6.9%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market2.8%

Stable Share Price: EDAP is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: EDAP's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1979227Marc Oczachowskihttps://www.edap-tms.com

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications.

EDAP TMS Fundamentals Summary

How do EDAP TMS's earnings and revenue compare to its market cap?
EDAP fundamental statistics
Market CapUS$271.58m
Earnings (TTM)US$2.44m
Revenue (TTM)US$48.76m

111.2x

P/E Ratio

5.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EDAP income statement (TTM)
Revenue€50.56m
Cost of Revenue€28.77m
Gross Profit€21.79m
Other Expenses€19.26m
Earnings€2.53m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.076
Gross Margin43.10%
Net Profit Margin5.01%
Debt/Equity Ratio17.0%

How did EDAP perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is EDAP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EDAP?

Other financial metrics that can be useful for relative valuation.

EDAP key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.8x
Enterprise Value/EBITDA-1777.1x
PEG Ratio2x

Price to Earnings Ratio vs Peers

How does EDAP's PE Ratio compare to its peers?

EDAP PE Ratio vs Peers
The above table shows the PE ratio for EDAP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average21x
SRTS Sensus Healthcare
8.1x-29.9%US$203.1m
IRMD IRadimed
31.5x12.6%US$383.7m
SMLR Semler Scientific
20.4x5.7%US$266.6m
RBOT Vicarious Surgical
24x-14.0%US$426.0m
EDAP EDAP TMS
111.2x55.4%US$271.6m

Price-To-Earnings vs Peers: EDAP is expensive based on its Price-To-Earnings Ratio (111.2x) compared to the peer average (21x).


Price to Earnings Ratio vs Industry

How does EDAP's PE Ratio compare vs other companies in the US Medical Equipment Industry?

Price-To-Earnings vs Industry: EDAP is expensive based on its Price-To-Earnings Ratio (111.2x) compared to the US Medical Equipment industry average (31.9x)


Price to Earnings Ratio vs Fair Ratio

What is EDAP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EDAP PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio111.2x
Fair PE Ratio57.9x

Price-To-Earnings vs Fair Ratio: EDAP is expensive based on its Price-To-Earnings Ratio (111.2x) compared to the estimated Fair Price-To-Earnings Ratio (57.9x).


Share Price vs Fair Value

What is the Fair Price of EDAP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: EDAP ($8.12) is trading above our estimate of fair value ($2.18)

Significantly Below Fair Value: EDAP is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies

Future Growth

How is EDAP TMS forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

4/6

Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


55.4%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: EDAP's forecast earnings growth (55.4% per year) is above the savings rate (1.9%).

Earnings vs Market: EDAP's earnings (55.4% per year) are forecast to grow faster than the US market (14.8% per year).

High Growth Earnings: EDAP's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: EDAP's revenue (15.3% per year) is forecast to grow faster than the US market (7.6% per year).

High Growth Revenue: EDAP's revenue (15.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if EDAP's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has EDAP TMS performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


26.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: EDAP has high quality earnings.

Growing Profit Margin: EDAP's current net profit margins (5%) are higher than last year (0.3%).


Past Earnings Growth Analysis

Earnings Trend: EDAP has become profitable over the past 5 years, growing earnings by 26.7% per year.

Accelerating Growth: EDAP's earnings growth over the past year (1864.3%) exceeds its 5-year average (26.7% per year).

Earnings vs Industry: EDAP earnings growth over the past year (1864.3%) exceeded the Medical Equipment industry 0.6%.


Return on Equity

High ROE: EDAP's Return on Equity (4.8%) is considered low.


Discover strong past performing companies

Financial Health

How is EDAP TMS's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: EDAP's short term assets (€70.9M) exceed its short term liabilities (€19.8M).

Long Term Liabilities: EDAP's short term assets (€70.9M) exceed its long term liabilities (€9.2M).


Debt to Equity History and Analysis

Debt Level: EDAP has more cash than its total debt.

Reducing Debt: EDAP's debt to equity ratio has increased from 6.8% to 17% over the past 5 years.

Debt Coverage: EDAP's debt is well covered by operating cash flow (55.8%).

Interest Coverage: Insufficient data to determine if EDAP's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Dividend

What is EDAP TMS current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

EDAP TMS Dividend Yield vs Market
How does EDAP TMS dividend yield compare to the market?
SegmentDividend Yield
Company (EDAP TMS)n/a
Market Bottom 25% (US)1.6%
Market Top 25% (US)4.6%
Industry Average (Medical Equipment)1.9%
Analyst forecast in 3 Years (EDAP TMS)n/a

Notable Dividend: Unable to evaluate EDAP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate EDAP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if EDAP's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if EDAP's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as EDAP has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

4.8yrs

Average management tenure


CEO

Marc Oczachowski (52 yo)

5.17yrs

Tenure

Mr. Marc Oczachowski has been Chief Executive Officer of EDAP TMS SA since March 31, 2007 and its Executive Director since July 1, 2017. Mr. Oczachowski serves as Executive Chairman of the Board at EDAP TM...


Leadership Team

Experienced Management: EDAP's management team is considered experienced (4.8 years average tenure).


Board Members

Experienced Board: EDAP's board of directors are seasoned and experienced ( 13.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of EDAP?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds3,284,1899.8%
Institutions7,809,53823.3%
General Public22,372,40966.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 32.91% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.81%
Soleus Capital Management, L.P.
3,284,189€26.7m4.31%3.94%
9.49%
Morgan Stanley, Investment Banking and Brokerage Investments
3,175,254€25.8m44.55%no data
2.72%
Rock Springs Capital Management LP
910,000€7.4m10.98%0.2%
2.02%
Archon Capital Management LLC
675,081€5.5m0%2.2%
1.69%
Bruce & Co Inc
565,652€4.6m0%1.11%
1.65%
PSM Vermögensverwaltung GmbH Langen v.d. Goltz & Partner
553,643€4.5m-1.77%36.66%
1.31%
Tacirler Portföy Yönetimi AS
439,106€3.6m0%2.71%
0.53%
Hauck & AufhÄUser Fund Services S.A.
179,039€1.5m0%0.09%
0.5%
Allspring Global Investments, LLC
168,285€1.4m68.66%no data
0.4%
Ohe Financial Inc
134,960€1.1m0%0.23%
0.4%
Worth Venture Partners, LLC
134,432€1.1m0%3.65%
0.38%
Peregrine Capital Management, LLC
127,295€1.0m152.17%0.03%
0.33%
Cetera Financial Holdings, Inc., Asset Management Arm
110,218€894.4k0%0.01%
0.27%
Orion Capital Management LLC
91,203€740.1k-0.65%0.56%
0.21%
PSM Vermogenswerwaltung GmbH
71,749€582.2k0%56.7%
0.2%
Manatuck Hill Partners, LLC
67,251€545.7k0%0.25%
0.19%
Susquehanna International Group, LLP, Asset Management Arm
63,616€516.2k159.36%no data
0.16%
Wilcoxson Wealth Management
52,225€423.8k8.29%no data
0.13%
BG Fund Management Luxembourg S.A.
42,000€340.8k0%0.01%
0.12%
Accredited Investors, Inc.
39,261€318.6k0%0.04%
0.09%
Schonfeld Strategic Advisors LLC
30,200€245.1k0.33%no data
0.089%
Citadel Advisors LLC
29,698€241.0k0%no data
0.084%
Saturna Capital Corporation
28,100€228.0k0%0.01%
0.068%
Geode Capital Management, LLC
22,764€184.7k0%no data
0.051%
HighTower Advisors, LLC
17,058€138.4k-33.26%no data

Company Information

EDAP TMS S.A.'s employee growth, exchange listings and data sources


Key Information

  • Name: EDAP TMS S.A.
  • Ticker: EDAP
  • Exchange: NasdaqGM
  • Founded: 1979
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$271.578m
  • Shares outstanding: 33.47m
  • Website: https://www.edap-tms.com

Number of Employees


Location

  • EDAP TMS S.A.
  • Parc dActivites la Poudrette-Lamartine
  • 4/6, rue du DauphinE
  • Lyon
  • Rhône-Alpes
  • 69120
  • France


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EDAPNasdaqGM (Nasdaq Global Market)YesADS EACH REPR 1 ORD SHARE FRF0.8USUSDAug 1997
EDADB (Deutsche Boerse AG)YesADS EACH REPR 1 ORD SHARE FRF0.8DEEURAug 1997

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/28 00:00
End of Day Share Price2022/09/28 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.